Levoketoconazole and Fosamprenavir: Interaction Details
- Fosamprenavir
- Lexiva
- Levoketoconazole
- Recorlev
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Levoketoconazole and Fosamprenavir interaction:
Levoketoconazole
- Recorlev
What Happens When You Take Levoketoconazole With Fosamprenavir
What can happen when they are taken together (rated Major)
Increased levoketoconazole exposure and increased risk of levoketoconazole-related adverse effects
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Levoketoconazole is a and fosamprenavir inhibits CYP3A4, so taking them together may raise levoketoconazole and heighten the risk of levoketoconazole-related adverse reactions. Strong CYP3A4 are not recommended for with levoketoconazole. These drugs should be avoided beginning 2 weeks prior to levoketoconazole therapy and throughout the treatment period.1
The Levoketoconazole and Fosamprenavir Interaction, Explained
Fosamprenavir (Lexiva), an HIV medicine, can slow the way your body breaks down levoketoconazole (Recorlev), a medicine used for high cortisol levels in Cushing's syndrome. That can let more levoketoconazole build up in your blood, which may raise the chance of side effects from it, such as liver problems or heart rhythm changes.
This warning is based on how the drugs are known to work in the body rather than on a large body of patient studies. Even so, the label says this combination should be avoided, including for 2 weeks before starting levoketoconazole. Please don't stop or change either medicine on your own. Talk with your pharmacist or doctor, who can review your options and plan a safer approach for you.
Mechanism: Fosamprenavir ( of amprenavir, a ) may inhibit CYP3A4-mediated of levoketoconazole, a CYP3A4 , increasing exposure (/) and the risk of dose-related adverse effects (e.g., , ).
- Evidence: theoretical, based on labeled CYP3A4 interaction data; onset unspecified.
- Severity: major. Strong CYP3A4 with levoketoconazole are not recommended.
- Management: avoid fosamprenavir for 2 weeks before and during levoketoconazole treatment. If this cannot be avoided, consider an alternative antiretroviral or therapy, with individualized dosing and closer monitoring (LFTs, /) per the care team.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Levoketoconazole and Fosamprenavir Interact
The likely mechanism
of -mediated of levoketoconazole
How to Manage the Levoketoconazole and Fosamprenavir Interaction
The documented advice is to avoid this combination. Fosamprenavir should not be used for 2 weeks before and during levoketoconazole treatment.
- Keep taking your medicines as prescribed until your prescriber tells you otherwise.
- Tell your pharmacist and prescriber (both HIV and Cushing's care teams) that you take both drugs.
- Your care team may choose a different medicine or plan the timing carefully, and may monitor you more closely if the combination is needed.
- Report symptoms such as yellowing of skin or eyes, dark urine, severe tiredness, nausea, or fainting or palpitations.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Levoketoconazole or Fosamprenavir need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Levoketoconazole and Fosamprenavir: Common Questions
How serious is the Levoketoconazole and Fosamprenavir interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Levoketoconazole and Fosamprenavir interaction managed?
The documented advice is to avoid this combination. Fosamprenavir should not be used for 2 weeks before and during levoketoconazole treatment. Keep taking your medicines as prescribed until your prescriber tells you otherwise. Tell your pharmacist and prescriber (both HIV and Cushing's care teams) that you take both drugs. Your care team may choose a different medicine or plan the timing carefully… Management is individual — always follow your own care team's guidance.
Does taking Levoketoconazole and Fosamprenavir at different times of day help?
No. Taking them at different times of day does not prevent this one. Fosamprenavir slows , an enzyme that breaks down levoketoconazole, so levoketoconazole can build up in the body. That change lasts while fosamprenavir is being taken and can continue for a while after the last dose.
Your pharmacist or prescriber can tell you how they will manage it.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Levoketoconazole and Fosamprenavir Interaction
Ask in your own words about taking Levoketoconazole and Fosamprenavir together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: RECORLEV(R) oral tablets, levoketoconazole oral tablets. Xeris Pharmaceuticals Inc (per manufacturer), Chicago, IL, 2021. DailyMed
Other Serious Interactions of Levoketoconazole and Fosamprenavir
Also serious with Fosamprenavir
- SimvastatinContraindicated
- AlfuzosinContraindicated
- Dihydroergotamine InjectionContraindicated
- Dihydroergotamine Nasal SprayContraindicated
Also serious with Levoketoconazole
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Fosamprenavir
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- GrapeModerate
- + 140 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.